Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research organization (CRO) under the umbrella of JSR Life Sciences and…
Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma Genmab A/S, a leading international biotechnology company specializing in the development of antibody therapeutics for the treatment of cancer and other serious diseases, announced today its intention…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research collaboration with Eli Lilly and Company, one of the world’s…
QIAGEN Enhances Digital PCR Lineup With New Lentivirus Tools for Cell and Gene Therapy QC In a move that further cements its position as a key player in the evolving field of cell and gene therapy (CGT), QIAGEN N.V.; Frankfurt…
Alnylam Secures Positive CHMP Recommendation for Vutrisiran in Treating ATTR Amyloidosis with Cardiomyopathy In a significant regulatory milestone for RNA interference (RNAi) therapeutics, Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the industry leader in RNAi-based drug development, has announced that the Committee…
nChroma Bio to Present at ASGCT 2025 Annual Meeting nChroma Bio, an emerging leader in the field of genetic medicines, today announced the acceptance of three significant scientific abstracts at the 28th Annual Meeting of the American Society of Gene…
Pfizer Champions a New Era in Personalized Cancer Care at ASCO 2025 Annual Meeting Pfizer Inc. (NYSE: PFE), a global leader in biopharmaceutical innovation, announced its robust presence at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting, which…
Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer Halda Therapeutics, a clinical-stage biotechnology company pioneering a new class of cancer therapeutics, has announced the appointment of Dr. Eyal Attar as its Chief Medical Officer (CMO). The strategic…
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to harness artificial intelligence (AI) and machine learning (ML) technologies in…
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer Secretome Therapeutics, a pioneering clinical-stage biotechnology company dedicated to advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), is pleased to announce the appointment of Marshelle Smith Warren,…
UK MHRA Approves Blenrep Combos for Relapsed/Refractory Multiple Myeloma GSK plc has achieved a critical regulatory milestone with the Medicines and Healthcare products Regulatory Agency (MHRA) granting authorisation for expanded use of Blenrep (belantamab mafodotin-blmf) in the United Kingdom. This…
Africa CDC and WHO Revise Mpox Strategy Amid Ongoing Outbreaks In a significant development aimed at containing the ongoing mpox outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) have jointly revised…